Advertisement
Thursday, November 19, 2026NewslettersAdvertiseWatch FL1
GET LOCALGo ad-freeHigh school sportsLocal eventsObituaries
News

Boosters could make vaccine manufacturers billions if they become broadly approved

Boosters could make vaccine manufacturers billions if they become broadly approved

If boosters become available to everyone, vaccine makers are on track to make billions.

Though President Joe Biden’s administration has made it seem that everyone could get the booster, the FDA and CDC have rejected the plan.

Leaders believe it will only be a matter of time before the boosters become more widely available.


If it becomes more broad on top of the increase in vaccinations, Pfizer and Moderna specifically will make a large profit.

Moderna’s projected revenue for 2022 jumped 35% when Biden announced the booster shot plans in August.

While the number of people who will end up getting booster shots has yet to be determined, Morningstar analyst Karen Andersen believes boosters will bring $26 billion in for Pfizer and $14 billion for Moderna.

The revenue coming in for COVID-19 vaccines and boosters has already greatly surpassed many other vaccines, including AbbVie’s rheumatoid arthritis treatment Humira, which is the best selling drug on the market globally.

Categories: NewsHealthBusiness

Want to go ad-free?

Become an FL1 member and say goodbye to ads! Plus, you’ll be supporting a company rooted in the Finger Lakes for nearly 30 years.

$4.99 / month

Get ad-free access

Renews monthly. Cancel anytime through your account. Already contributing via Google? Sign in with your Google account and unlock ad-free access. Embedded YouTube videos and other third-party media players may still contain ads.

Start your day with FingerLakes1

Get the stories that matter from across the Finger Lakes, delivered to your inbox.

Your email will be added to our newsletter mailing list, hosted on Substack. Privacy policy